Filing Details

Accession Number:
0001179110-15-014354
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-03 12:05:05
Reporting Period:
2015-10-30
Filing Date:
2015-11-03
Accepted Time:
2015-11-03 12:05:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
855654 Immunogen Inc IMGN Pharmaceutical Preparations (2834) 042726691
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1094159 M Daniel Junius 830 Winter Street
Waltham MA 02451
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-10-30 5,575 $4.29 159,690 No 4 M Direct
Common Stock Acquisiton 2015-10-30 122 $5.77 159,812 No 4 M Direct
Common Stock Acquisiton 2015-11-02 5,497 $3.19 165,309 No 4 M Direct
Common Stock Disposition 2015-11-02 5,497 $12.00 159,812 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-10-30 5,575 $4.29 5,575 $4.29
Common Stock Stock Option (right to buy) Disposition 2015-10-30 122 $5.77 122 $5.77
Common Stock Stock Option (right to buy) Disposition 2015-11-02 5,497 $3.19 5,497 $3.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
194,425 2010-01-01 2019-01-01 No 4 M Direct
62,669 2008-06-12 2017-06-12 No 4 M Direct
37,917 2007-06-08 2016-06-08 No 4 M Direct
Footnotes
  1. This transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan executed by the reporting person on June 1, 2015.
  2. Exercisable as to 21,667 shares commencing on June 8, 2007, 21,667 shares commencing on June 8, 2008, and 21,666 shares commencing on June 8, 2009.
  3. Exercisable as to 50,000 shares commencing on January 1, 2010, 50,000 shares commencing on January 1, 2011, 50,000 shares commencing on January 1, 2012 and 50,000 shares commencing on January 1, 2013.
  4. Exercisable as to 26,667 shares commencing on June 12, 2008, 26,667 shares commencing on June 12, 2009, and 26,666 shares commencing on June 12, 2010.